Omacetaxine Mepesuccinate

Category: Cancer



Omacetaxine Mepesuccinate Overview

Omacetaxine mepesuccinate (INN, trade names Synribo ), formerly named as homoharringtonine or HHT, is a pharmaceutical drug substance that is indicated for treatment of chronic myeloid leukemia (CML). HHT is a natural plant alkaloid derived from Cephalotaxus fortunei. HHT and related compound esters of cephalotaxine were described first in 1970, and were the subject of intensive research efforts by Chinese investigators to clarify their role as anticancer and antileukemic agents from the 1970...

Read more Omacetaxine Mepesuccinate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Omacetaxine_mepesuccinate

Recent Omacetaxine Mepesuccinate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Omacetaxine Mepesuccinate
  • Injection: 3.5mg/vial
  • Powder: 3.5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Omacetaxine Mepesuccinate or a similar ingredient: (1 result)

  • SYNRIBO Omacetaxine Mepesuccinate